+500
篇科學發表論文
全球20
間實驗室
+ 600
名專業人員
+4
項專利
最新消息
台灣艾捷隆–致力於ESG與友善家庭的歐洲基因檢測服務專家
作為歐洲在台商務協會( European Chamber of Commerce Taiwan,ECCT )的友善家庭聯盟( Family Friendly Alliance,FFA ) 成員之一,我們堅信企業成功與否,不僅取決於經濟效益,更在於企業能夠如何對社會和環境作出貢獻,因此我們積極參與各項社會活動,並且以實際行動回饋社會。
關於 Igenomix 台灣艾捷隆
ERA Official Statement
We recognize the importance of addressing the ongoing concerns surrounding the paper titled “Personalized embryo transfer reduces success rates because endometrial receptivity analysis fails to accurately identify the window of implantation” by Kevin S. Richter and Martin L. Richter. We are fully committed to supporting you and standing by your side. Our main objective is to ensure that accurate information about our services reaches everyone. We are concerned about the potential impact misinformation can have on your patients. As experts in the field, we are firmly dedicated to sharing the correct data and providing clear guidance on the appropriate use of our services.
At Igenomix, we consistently leverage scientific advancements and stay at the forefront of research to enhance the accuracy and reliability of the ERA test. The credibility of the ERA test stems from its extensive scientific validation, with numerous publications confirming its effectiveness. Since 2011, over 200,000 women worldwide have undergone the ERA test provided by Igenomix.
The ERA test has yielded proven results, with more than 20 clinical studies conducted globally supporting its utilization. It was introduced as a solution for women experiencing repeated failed embryo transfers. When applied to this specific target population, the ERA test significantly increases the chances of achieving a successful pregnancy. Our goal at Igenomix is a healthy baby at home, and we are committed to making this a reality for our patients sooner rather than later.
You are welcome to connect with our scientific community for detailed explanations and support. Rest assured that we will stand by your side and assist you in helping your patients achieve a healthy pregnancy. Contact us by using the information listed below: